Novo Nordisk A/S (NVO) Dividend Yield, History & Forecast

Novo Nordisk A/S (NVO) is a Drug Manufacturers - General company in the Healthcare sector listed on the New York Stock Exchange. It pays a current dividend yield of 4.18% ($11.70 per share annually (TTM)), with 6 years of consecutive dividend increases. The most recent ex-dividend date was March 30, 2026, with payment scheduled for April 8, 2026. The trailing twelve-month payout ratio is 42.5%; the market capitalization is approximately $164.32B.

Loading quote...

Frequently Asked Questions about Novo Nordisk A/S (NVO)

What is Novo Nordisk A/S's dividend yield?
Novo Nordisk A/S (NVO) pays a current trailing twelve-month dividend yield of 4.18%, which works out to $11.70 per share annually based on the most recent payout schedule.
When does Novo Nordisk A/S pay its next dividend?
The most recent ex-dividend date was March 30, 2026. The next scheduled dividend payment date is April 8, 2026.
How many years has Novo Nordisk A/S increased its dividend?
Novo Nordisk A/S (NVO) has increased its dividend for 6 consecutive years.
Is Novo Nordisk A/S a Dividend Aristocrat?
No. Dividend Aristocrat status requires an S&P 500 listing and 25 or more consecutive years of dividend increases. Novo Nordisk A/S (NVO) currently has 6 years of consecutive increases.
What sector is Novo Nordisk A/S in?
Novo Nordisk A/S (NVO) operates in the Healthcare sector, specifically the Drug Manufacturers - General industry.
What is Novo Nordisk A/S's dividend payout ratio?
Novo Nordisk A/S (NVO)'s trailing twelve-month dividend payout ratio is 42.5%. The payout ratio measures what percentage of earnings is paid out as dividends — a lower ratio generally suggests a more sustainable dividend.